Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
PATENT LAW AND COMMUNITY INTEREST IN PUBLIC HEALTH: SHOULD PATENT LAW BE SUPPLEMENTED BY A HEALTH IMPACT FUND, Jowa Chan

PATENT LAW AND COMMUNITY INTEREST IN PUBLIC HEALTH: SHOULD PATENT LAW BE SUPPLEMENTED BY A HEALTH IMPACT FUND, Jowa Chan

Ratings: (0)|Views: 99|Likes:
Published by Brendan Gogarty
This article explores the lively issue of whether using the patent system as a one-size- fits-all system to regulate the pharmaceutical industry is justified. In assessing the shortcomings of the patent system, this paper will discuss the problems inherent in the patent system, which result from its reliance on market forces to generate royalties to incentivise pharmaceutical research and development. It will be argued that the system at present does not sufficiently account for public health interests, a dimension unique to the pharmaceutical research and development industry. By linking financial returns to market demand for a product at monopolistic prices, an incentive system rewards the marketing of a product to consumers able to pay for the product, and not necessarily the health benefits of that product conferred on the community. Consequently, this article contends that reform is necessary.
The proposal of a Health Impact Fund, as advocated by Professor Thomas Pogge and Professor Aidan Hollis, will then be evaluated as a national scheme in the context of Australia's regulatory environment in the latter part of this article. The advantages of a Health Impact Fund, a prize system using a direct measure of health benefits for pharmaceutical treatments registered with the fund to determine the size of the prizes, will be explored and a critique of the adoption of such a system to complement the Australian patent system will be made. The current practical and legal challenges faced in implementing such a system will be discussed. Despite the potential obstacles in implementing a Health Impact Fund on a national scale, this article contends that having a voluntary scheme to complement the existing patent system is a beneficial option that is worth considering in light of the recent focus on pharmaceutical patent reform.
This article explores the lively issue of whether using the patent system as a one-size- fits-all system to regulate the pharmaceutical industry is justified. In assessing the shortcomings of the patent system, this paper will discuss the problems inherent in the patent system, which result from its reliance on market forces to generate royalties to incentivise pharmaceutical research and development. It will be argued that the system at present does not sufficiently account for public health interests, a dimension unique to the pharmaceutical research and development industry. By linking financial returns to market demand for a product at monopolistic prices, an incentive system rewards the marketing of a product to consumers able to pay for the product, and not necessarily the health benefits of that product conferred on the community. Consequently, this article contends that reform is necessary.
The proposal of a Health Impact Fund, as advocated by Professor Thomas Pogge and Professor Aidan Hollis, will then be evaluated as a national scheme in the context of Australia's regulatory environment in the latter part of this article. The advantages of a Health Impact Fund, a prize system using a direct measure of health benefits for pharmaceutical treatments registered with the fund to determine the size of the prizes, will be explored and a critique of the adoption of such a system to complement the Australian patent system will be made. The current practical and legal challenges faced in implementing such a system will be discussed. Despite the potential obstacles in implementing a Health Impact Fund on a national scale, this article contends that having a voluntary scheme to complement the existing patent system is a beneficial option that is worth considering in light of the recent focus on pharmaceutical patent reform.

More info:

Categories:Types, Presentations
Published by: Brendan Gogarty on Jun 16, 2014
Copyright:Traditional Copyright: All rights reserved

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
See more
See less

07/02/2014

 
 "#$%&'
!"#$%# '"( "%) *+,,-%.#/ .%#$4$5# .% !-?'.* 2$"'#2: 52+-') !"#$%# '"( ?$ 5-!!'$,$%#$) ?/ " 2$"'#2 .,!"*# 7-%)9
 ()$*+,'
<0=6 *861
-(. /4$& 54??,+2&: 7+, ?,#9$<' 0= (?,#% 6=81 />;' 8=3DEEOBJG;I36=803603L*4938
Kctg tc usgrs6
Ertmbags mk t`g ‐Gpuos e`gej ci prmkt” (GET) sgbtmck erg pggr rgvmgwgj ebbgptgj ertmbags tc og puoams`gj mk t`ms fcurkea. Tagesg og ewerg t`et eat`cul` GETs jc kct `evg eaa omoamclrep`mb jgtemas evemaeoag ygt, t`gy bek og bmtgj usmkl t`g yger ci ckamkg puoambetmck ekj t`g Jmlmtea Cofgbt Mjgktmimgr (JCM) es icaacws6 Eut`cr(s), ‐Ertmbag Zmtag”, Fcurkea (]ger), JCM, GET (pelg #). Z`g GET pelg kunogr wmaa og rgtemkgj mk t`g octtcn nerlmk ci t`g prmktgj vgrsmck ci t`ms ertmbag w`gk mt ms bcaaetgj mk e prmkt mssug. Bcaaetgj prmkt vgrsmcks ci t`g ertmbag wmaa bcktemk ek ejjmtmckea vcaungtrmb pelg kunogr. Oct` pelg bmtetmcks wmaa og rgagvekt, out eky GET rgigrgkbg nust bcktmkug tc  og prgbgjgj oy t`g agttgrs GET. MRRK-4<?=-5:07 Bcpyrml`t
!
 ?45: Wkmvgrsmty ci Zesnekme Eaa rml`ts rgsgrvgj. Ruofgbt tc t`g aew ci bcpyrml`t kc pert ci t`ms puoambetmck ney og rgprcjubgj, stcrgj mk e rgtrmgvea systgn cr treksnmttgj mk eky icrn cr  oy eky ngeks gagbtrckmb, ngb`ekmbea, p`ctcbcpymkl, rgbcrjmkl cr ct`grwmsg, wmt`cut t`g pgrnmssmck ci t`g cwkgr ci t`g bcpyrml`t. Eaa gkqumrmgs sgghmkl pgrnmssmck tc rgprcjubg eky pert ci t`ms puoambetmck s`cuaj og ejjrgssgj mk t`g imrst mkstekbg tc6 Z`g Gjmtcr, Fcurkea ci Aew, Mkicrnetmck ekj Rbmgkbg, Trmvetg Oel 0=, @coert, Zesnekme <445, Eustreame. gjmtcrDfamsfcurkea.crl `ttp6//www.famsfcurkea.crl/
 
 GET 5
 
T
EZGKZ
A
E\ EKJ
B
CNNWKMZ]
M
KZG_GRZ MK
T
WOAMB
@
GEAZ@
6
 
R
@CWAJ
T
EZGKZ
A
E\ OG RWTTAGNGKZGJ O] E
@
GEAZ@
M
NTEBZ
I
WKJ
3
F
C\E
B
@EK
*
 Eostrebt
Z`ms ertmbag gxpacrgs t`g amvgay mssug ci w`gt`gr usmkl t`g petgkt systgn es e ckg-smzg- imts-eaa systgn tc rgluaetg t`g p`ernebgutmbea mkjustry ms fustmimgj. Mk essgssmkl t`g s`crtbcnmkls ci t`g petgkt systgn, t`ms pepgr wmaa jmsbuss t`g prcoagns mk`grgkt mk t`g petgkt systgn, w`mb` rgsuat ircn mts rgamekbg ck nerhgt icrbgs tc lgkgretg rcyeatmgs tc mkbgktmvmsg p`ernebgutmbea rgsgerb` ekj jgvgacpngkt. Mt wmaa og erlugj t`et t`g systgn et prgsgkt jcgs kct suiimbmgktay ebbcukt icr puoamb `geat` mktgrgsts, e jmngksmck ukmqug tc t`g p`ernebgutmbea rgsgerb` ekj jgvgacpngkt mkjustry. Oy amkhmkl imkekbmea rgturks tc nerhgt jgnekj icr e prcjubt et nckcpcamstmb prmbgs, ek mkbgktmvg systgn rgwerjs t`g nerhgtmkl ci e prcjubt tc bcksungrs eoag tc pey icr t`g  prcjubt, ekj kct kgbgssermay t`g `geat` ogkgimts ci t`et prcjubt bckigrrgj ck t`g bcnnukmty. Bcksgqugktay, t`ms ertmbag bcktgkjs t`et rgicrn ms kgbgssery. Z`g prcpcsea ci e @geat` Mnpebt Iukj, es ejvcbetgj oy Trcigsscr Z`cnes Tcllg ekj Trcigsscr Emjek @caams, wmaa t`gk og gveauetgj es e ketmckea sb`gng mk t`g bcktgxt ci Eustreame's rgluaetcry gkvmrckngkt mk t`g aettgr pert ci t`ms ertmbag. Z`g ejvektelgs ci e @geat` Mnpebt Iukj, e prmzg systgn usmkl e jmrgbt ngesurg ci `geat` ogkgimts icr  p`ernebgutmbea trgetngkts rglmstgrgj wmt` t`g iukj tc jgtgrnmkg t`g smzg ci t`g  prmzgs, wmaa og gxpacrgj ekj e brmtmqug ci t`g ejcptmck ci sub` e systgn tc bcnpagngkt t`g Eustreamek petgkt systgn wmaa og nejg. Z`g burrgkt prebtmbea ekj aglea b`eaagklgs  iebgj mk mnpagngktmkl sub` e systgn wmaa og jmsbussgj. Jgspmtg t`g pctgktmea costebags mk mnpagngktmkl e @geat` Mnpebt Iukj ck e ketmckea sbeag, t`ms ertmbag bcktgkjs t`et `evmkl e vcauktery sb`gng tc bcnpagngkt t`g gxmstmkl petgkt systgn ms e ogkgimbmea cptmck t`et ms wcrt` bcksmjgrmkl mk aml`t ci t`g rgbgkt icbus ck p`ernebgutmbea petgkt rgicrn.
Mktrcjubtmck
Z`g rcag ci petgkt aew mk t`g imgaj ci rgsgerb` ekj jgvgacpngkt mktc ngjmbmkgs ekj t`gmr ngt`cjs ci usg, w`mb` icr t`g purpcsgs ci t`ms pepgr wmaa  og rgigrrgj tc es p`ernebgutmbea rgsgerb` ekj jgvgacpngkt, `es ackl oggk e tcpmb icr pessmcketg jgoetg. Mk Eustreame, ejvcbetgs icr strcklgr petgkt
*
 ORb, AAO (@cks) Wkmvgrsmty ci Kgw Rcut` \eags. Rmkbgrg t`ekhs tc Jr Bet`grmkg Ockj ekj twc ekckyncus rgvmgwgrs icr iggjoebh jurmkl t`g jreitmkl ci t`ms pepgr.

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->